Frontage Holdings Corporation
FGHQF
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.24B
Close$
Share Statistics
| Market cap | $2.24 Billion |
|---|---|
| Enterprise Value | $2.38 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.18 |
| Outstanding Shares | 2,029,748,194 |
Return
| Return on Equity | 4.07% |
|---|---|
| Return on Assets | 2.49% |
| Return on Invested Capital | 7.61% |
Valuation & Multiples
| P/E Ratio | 27.08 |
|---|---|
| PEG | 20.8 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.49 |
| Enterprise Value to EBIT | 67.95 |
| Enterprise Value to Net Income | 165 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.5 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$135.44 M
Average shareholder expectationNext Earnings Call
Expected Date
March 29, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$150.21 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Frontage Holdings Corporation
1,800 employees
CEO: Zhongping Lin Frontage Holdings Corporation functions as a contract research organization (CRO), delivering a broad spectrum of laboratory and associated services to the pharmaceutical, biotechnology, and agrochemical sectors, alongside performing vit...